TY - JOUR T1 - Viral And Antibody Testing For Coronavirus Disease 2019 (Covid-19): Factors Associated With Positivity In Electronic Health Records From The United States JF - medRxiv DO - 10.1101/2021.03.19.21253924 SP - 2021.03.19.21253924 AU - Lisa Lindsay AU - Matthew H. Secrest AU - Shemra Rizzo AU - Dan Keebler AU - Fei Yang AU - Larry W. Tsai Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/24/2021.03.19.21253924.abstract N2 - Background Insufficient information on SARS-CoV-2 testing results exists in clinical practice from the United States.Methods We conducted an observational retrospective cohort study using OptumĀ® de-identified COVID-19 electronic health records from the United States to characterize patients who received a SARS-CoV-2 viral or antibody test between February 20, 2020 and July 10, 2020. We assessed temporal trends in testing and positivity by demographic and clinical characteristics; evaluated concordance between viral and antibody tests; and identified factors associated with positivity via multivariable logistic regression.Results Our study population included 891,754 patients. Overall positivity rate for SARS-CoV-2 was 9% and 12% for viral and antibody tests, respectively. Positivity rate was inversely associated with the number of individuals tested and decreased over time across regions and race/ethnicities. Among patients who received a viral test followed by an antibody test, concordance ranged from 90%-93% depending on the duration between the two tests which is notable given uncertainties related to specific viral and antibody test characteristics. The following factors increased the odds of viral and antibody positivity in multivariable models: male, Hispanic or non-Hispanic Black and Asian, uninsured or Medicaid insurance, Northeast residence, dementia, diabetes, and obesity. Charlson Comorbidity Index was negatively associated with test positivity. We identified symptoms that were positively associated with test positivity, as well as, commonly co-occurring symptoms / conditions. Pediatric patients had reduced odds of a positive viral test, but conversely had increased odds of a positive antibody test.Conclusions This study identified sociodemographic and clinical factors associated with SARS-CoV-2 testing and positivity within routine clinical practice from the United States.Competing Interest StatementL.L., M.H.S., S.R., D.K., and L.T. are employed by and hold shares in Genentech, Inc. F.Y. is employed by and hold shares in Roche Diagnostics.Funding StatementGenentech Inc. and Roche Diagnostics funded employee/s time for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The use of Optum de-identified COVID-19 database was reviewed by the New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this study did not involve human subject research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from Optum but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Optum. ER -